KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Inventory: 2017-2025

Historic Inventory for Dynavax Technologies (DVAX) over the last 8 years, with Sep 2025 value amounting to $73.3 million.

  • Dynavax Technologies' Inventory rose 17.44% to $73.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.3 million, marking a year-over-year increase of 17.44%. This contributed to the annual value of $70.1 million for FY2024, which is 31.46% up from last year.
  • Latest data reveals that Dynavax Technologies reported Inventory of $73.3 million as of Q3 2025, which was down 3.17% from $75.7 million recorded in Q2 2025.
  • In the past 5 years, Dynavax Technologies' Inventory registered a high of $102.6 million during Q3 2022, and its lowest value of $49.4 million during Q3 2023.
  • Moreover, its 3-year median value for Inventory was $62.4 million (2024), whereas its average is $63.1 million.
  • Its Inventory has fluctuated over the past 5 years, first soared by 58.94% in 2021, then plummeted by 51.84% in 2023.
  • Over the past 5 years, Dynavax Technologies' Inventory (Quarterly) stood at $61.3 million in 2021, then fell by 3.08% to $59.4 million in 2022, then dropped by 10.36% to $53.3 million in 2023, then skyrocketed by 31.46% to $70.1 million in 2024, then grew by 17.44% to $73.3 million in 2025.
  • Its last three reported values are $73.3 million in Q3 2025, $75.7 million for Q2 2025, and $74.4 million during Q1 2025.